| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 363.975 | 18.376 | 0 | 181 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 368.829 | 18.376 | 0 | 181 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 349.085 | 22.999 | 0 | 10.766 | 0 | 0 | 0 | 10.159 | 10.128 | 10.072 |
| Gross Profit/Loss - EUR | 19.744 | -4.623 | 0 | -10.586 | 0 | 0 | 0 | -10.159 | -10.128 | -10.072 |
| Net Profit/Loss - EUR | 19.744 | -4.623 | 0 | -10.591 | 0 | 0 | 0 | -10.159 | -10.128 | -10.072 |
| Employees | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lupuzum Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.271 | 11.156 | 10.967 | 0 | 10.558 | 10.357 | 10.128 | 0 | 0 | 0 |
| Current Assets | 98.089 | 229 | 225 | 228 | 701 | 688 | 673 | 682 | 679 | 676 |
| Inventories | 97.372 | 210 | 206 | 203 | 199 | 195 | 191 | 191 | 191 | 190 |
| Receivables | 0 | 0 | 0 | 0 | 491 | 482 | 471 | 472 | 471 | 468 |
| Cash | 717 | 19 | 18 | 25 | 11 | 11 | 11 | 18 | 18 | 18 |
| Shareholders Funds | -10.816 | -15.329 | -15.070 | -25.384 | -14.506 | -14.231 | -13.916 | -24.118 | -24.045 | -23.911 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 120.176 | 26.714 | 26.262 | 25.612 | 25.765 | 25.277 | 24.716 | 24.800 | 24.725 | 24.586 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4639 - 4639" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Lupuzum Srl